Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2019 · 10-Q
Revenue$239.36M$239.36M−7.2% vs Q2 2018 Net Income$30.84M$30.84M+0.4% vs Q2 2018 EPS Diluted$0.59$0.59+3.5% vs Q2 2018 Gross Profit$137,472,000−4.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$39,255,000−27.9% Free Cash Flowderived$36,650,000−29.8% Margins · derivedGross margin57.4%+1.6 pt vs Q2 2018
Operating margin29.6%+0.1 pt vs Q2 2018
Net margin12.9%+1.0 pt vs Q2 2018
ended Sep 30, 2018 · filed Nov 1, 2018 · 32 d after period end